Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral blood vessel vasodilation involves the widening of blood vessels, primarily arteries and arterioles, leading to increased blood flow to tissues. It is crucial for regulating tissue perfusion, oxygenation, thermoregulation, and blood pressure. The process is mediated by various factors, including nitric oxide (NO) and other endothelium-derived relaxing factors, which induce relaxation of vascular smooth muscle cells. Impaired vasodilation contributes to diseases such as hypertension and peripheral artery disease. Vasodilators are used therapeutically to manage hypertension, angina, and heart failure.
Relaxation of vascular smooth muscle cells, primarily through nitric oxide (NO) signaling and other endothelium-derived relaxing factors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral Blood Vessel (Vasodilation).